Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Vor 3 Tagen · The Committee for Medicinal Products for Human Use ( CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines. Documents. Agenda of the CHMP meeting 27-30 May 2024. Draft Reference Number: EMA/CHMP/182386/2024. English (EN) (1.1 MB - PDF) First published: 27/05/2024. View.

  2. Vor 2 Tagen · The European Medicines Agency (EMA) makes upgrades to this website from time to time, to improve user experience. During these upgrades, the website is unavailable for a short period of time, outside of EMA working hours. This page lists when we are planning the next outage and the main improvements made. Corporate. Planned ...

  3. Vor 3 Tagen · Loganair / Operated by Blue Islands 5551. Jersey. (EMA Departures) Track the current status of flights departing from (EMA) East Midlands Airport using FlightStats flight tracker.

  4. Vor 22 Stunden · DTC’s commitment to developing critical communication solutions for mission success is reinforced by the appointment of Stephen Beeching as Senior Vice President for EMEA. Beeching's extensive ...

  5. Vor 4 Tagen · MSs should ensure that the procedure for granting a MA is completed within a maximum of 210 days after the submission of a valid application. Clock stops are possible. Legal basis: Artl. 8, 17, Directive 2001/83/EC; for variations: Artl. 4 (1), 5 (1) and 6 (1) of Regulation (EC) No 1084/2003. 1.4.

  6. Vor 3 Tagen · Overview of the evolution of the guideline, its scope and impact. Requirements for establishing reliability and accuracy of computerised systems used in trials. Non-technology related perspectives for sponsors such as processes, people, project delivery, financial, vendors and investigators.

  7. Vor einem Tag · An EPAR provides public information on a medicine, including how it was assessed by EMA. The EPAR reflects the scientific conclusions of the relevant EMA committee at the end of the assessment process, providing the grounds for the committee opinion on whether or not to approve an application. For products following the Central ...